𝔖 Bobbio Scriptorium
✦   LIBER   ✦

025 THE MESENCEPHALIC LOCOMOTOR REGION IN PATIENTS WITH FREEZING OF GAIT AND PARKINSON'S DISEASE: A MOTOR IMAGERY STUDY

✍ Scribed by A.H. Snijders; H.P. Leunissen; M. Bakker; S. Overeem; R.C.G. Helmich; R.V. van Oosten; I. Toni; B.R. Bloem

Book ID
117754086
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
46 KB
Volume
16
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Validation of the freezing of gait quest
Validation of the freezing of gait questionnaire in patients with Parkinson's disease
✍ Nir Giladi; Joseph Tal; Tali Azulay; Oliver Rascol; David J. Brooks; Eldad Melam πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 1 views

## Abstract To revalidate the Freezing of Gait Questionnaire (FOG‐Q), patients with Parkinson's disease (PD) were randomly assigned to receive rasagiline (1 mg/day) (n = 150), entacapone (200 mg with each dose of levodopa) (n = 150), or placebo (n = 154). Patients were assessed at baseline and afte

Cueing for freezing of gait in patients
Cueing for freezing of gait in patients with Parkinson's disease: A rehabilitation perspective
✍ Alice Nieuwboer πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 1 views

Freezing of gait (FOG) has been known to respond favorably to sensory tricks and cues. However, FOG is a complex phenomenon with various motor control deficits at play. In this review, we examined and summarized the currently available evidence for the effectiveness of cueing for FOG to determine it

Study of istradefylline in patients with
Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
✍ Robert A. Hauser; Lisa M. Shulman; Joel M. Trugman; John W. Roberts; Akihisa Mor πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 1 views

## Abstract The objective of this study was to evaluate the efficacy, safety, and tolerability of istradefylline 20 mg once daily versus placebo as an adjunct to levodopa in subjects with Parkinson's disease (PD) who have motor fluctuations. Istradefylline (KW‐6002) is an adenosine A~2A~ receptor a